Pyridines and pyrazines as inhibitors of PI3K

Details for Australian Patent Application No. 2009226958 (hide)

International Classifications

Event Publications

7 October 2010 PCT application entered the National Phase

PCT publication WO2009/115517 Priority application(s): WO2009/115517

14 October 2010 Corrigenda

PCT applications that have entered the National Phase - Name Index Under the name Novartis AG, Application No. 2009226958, under INID (54) correct the title to read Pyridines and pyrazines as inhibitors of PI3K. Specifications Republished The following specifications contained errors when advertised OPI, Specifications Republished Accepted or Certified. They have been reissued on the AU-A or AU-B CD-ROM of this Journal date. 2004242787 Mymetics Corporation 2004313440 Kimberly-Clark Worldwide, Inc. 20052454

14 June 2012 Application Accepted

Published as AU-B-2009226958

11 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.